NCT03962920招募中不适用
Personalized Treatment of Urogenital Cancers Depends on the Microbiome
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 28
- 试验地点
- 1
- 主要终点
- recurrence rate after surgical treatment of tumour
研究概览
简要总结
This is a randomized controlled trial where patients undergoing surgical treatment for urogenital cancers will be randomized in a two arms study: surgical treatment + antibiotics OR surgical treatment + placebo.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 40 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Biopsy verified diagnosis of urological cancer, localized disease
排除标准
- •Hospitalization within three months of surgery
- •Antibiotics within three months of surgery
- •Infectious disease, including UTI's within three months of surgery
- •History of cancers of the genitourinary tract
研究组 & 干预措施
Surgical treatment + antibiotics
Active Comparator
Use antibiotic
干预措施: Tigecycline 50 MG (Drug)
surgical treatment + placebo
Placebo Comparator
Use placebo
干预措施: Placebo (Other)
结局指标
主要结局
recurrence rate after surgical treatment of tumour
时间窗: 5 years after treatment
recurrence rate after surgical treatment of tumour
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
MOdified Urinary Conduit to Lower Strictures After radIcal CystectomyBladder CancerNCT04391790Jørgen Bjerggaard Jensen300
招募中
不适用
Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal NeobladderUrinary DiversionBladder CancerNCT03108196Zhujiang Hospital96
招募中
不适用
Personalizing therapy of urogenital cancer by metastatic tissue Immune profiling, Organoid culture, and NExt genERation sequencingUrigenital cancerbladder cancer and prostate cancer10038364NL-OMON46194Radboud Universitair Medisch Centrum150
已完成
2 期
Exisulind Versus Placebo After Surgical Removal of the ProstateProstatic NeoplasmsNCT00166426Mayo Clinic240
终止
4 期
Use of a Ureteral Access Sheath During Ureteroscopy and Its Effect on Stone Free RateUrinary CalculiNCT00199524Lawson Health Research Institute44